InvestorsHub Logo
Followers 79
Posts 24524
Boards Moderated 1
Alias Born 09/08/2000

Re: None

Wednesday, 01/03/2018 7:57:48 AM

Wednesday, January 03, 2018 7:57:48 AM

Post# of 27431
TRVN - 1.80 Pre-market now at 2.17/2.19

Trevena Announces FDA Acceptance for Review of New Drug Application for OLINVO™ (oliceridine) Injection




Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.